- Recent Funding
- Investors
- Biogen New Ventures
Biogen New Ventures portfolio
Biogen New Ventures has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is Estuary Biotherapeutics's $103M Series A round in October 2026, alongside 4BIO Capital, UPMC Enterprises, Deep Track Capital and 4 others. That company is in Health and bio.
What Biogen New Ventures invests in
- Health and bio · 1 · 100%
How Biogen New Ventures invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series A | 1 100% | $103M |
Biogen New Ventures portfolio companies
EEstuary Biotherapeutics$103MSeries A · Oct 2026
| Company | Round with Biogen New Ventures | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $103M | $103M | Oct 16, 2026 Series A |
Most frequent co-investors
GGV1 shared round · last Oct 16, 2026
RRA Capital Management1 shared round · last Oct 16, 2026
DDeep Track Capital1 shared round · last Oct 16, 2026
PPivotal bioVenture Partners1 shared round · last Oct 16, 2026
44BIO Capital1 shared round · last Oct 16, 2026
UUPMC Enterprises1 shared round · last Oct 16, 2026
NNational Kidney Foundation1 shared round · last Oct 16, 2026
Similar investors
AAvant Bio1 company · 1 deal in 12 mo
BBiospring Partners1 company · 1 deal in 12 mo
CColossa Ventures1 company · 1 deal in 12 moCCommerzbank1 company · 1 deal in 12 mo
CCultivian Sandbox Ventures1 company · 1 deal in 12 mo
FFiducia1 company · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Biogen New Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Biogen New Ventures, which is a subset of its real portfolio. API: /api/v1/investors/biogen-new-ventures (get a free API key). More: the most active VC firms and new venture capital funds.